News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Elizabeth D. Hermsen, PharmD, MBA

Advertisement

Articles by Elizabeth D. Hermsen, PharmD, MBA

Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a Seat

ByElizabeth D. Hermsen, PharmD, MBA
August 12th 2020

The pharmaceutical industry plays an essential role in advancing antimicrobial stewardship and addressing the growing threat of resistant pathogens.

Advertisement

Latest Updated Articles

  • Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a Seat
    Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a Seat

    Published: August 12th 2020 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Phase 3 Clinical Trial Reporting, Prospective Regulatory Filings to Watch For in 2026

2

Invasive Fungal Disease in Transplantation: Prevention in a Shifting Landscape

3

A No-Carb Diet: An Overview of Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacterales

4

Prospective Game Changer: Lenacapavir for HIV Preexposure Prophylaxis

5

Pertussis Cases Surge in Young Children, Adolescents Due to Reduced Vaccine Uptake

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us